{"id":"https://openalex.org/W2954553631","doi":"https://doi.org/10.1158/1538-7445.am2019-5019","title":"Abstract 5019: Allosteric inhibition of SHP2 suppresses CSF1R signaling and selectively reduces viability of M2 tumor associated macrophages contributing to anti-tumor immunity","display_name":"Abstract 5019: Allosteric inhibition of SHP2 suppresses CSF1R signaling and selectively reduces viability of M2 tumor associated macrophages contributing to anti-tumor immunity","publication_year":2019,"publication_date":"2019-07-01","ids":{"openalex":"https://openalex.org/W2954553631","doi":"https://doi.org/10.1158/1538-7445.am2019-5019","mag":"2954553631"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2019-5019","doi":"https://doi.org/10.1158/1538-7445.am2019-5019","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2019-5019","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023590155","display_name":"Elsa Quintana","orcid":"https://orcid.org/0000-0002-4123-1695","observed_orcids":["https://orcid.org/0000-0002-4123-1695"]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elsa Quintana","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA;","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085646397","display_name":"Chris J. Schulze","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chris J. Schulze","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA;","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055494036","display_name":"Tiffany J. Choy","orcid":"https://orcid.org/0000-0001-6501-2123","observed_orcids":["https://orcid.org/0000-0001-6501-2123"]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tiffany J. Choy","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA;","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058734302","display_name":"Darienne R. Myers","orcid":"https://orcid.org/0000-0001-9764-7369","observed_orcids":["https://orcid.org/0000-0001-9764-7369"]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Darienne R. Myers","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA;","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086374199","display_name":"Kasia Mordec","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kasia Mordec","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA;","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104388930","display_name":"Dylan Daniel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dylan Daniel","raw_affiliation_strings":["2MI Bioresearch, Ann Arbor, MI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2MI Bioresearch, Ann Arbor, MI","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021689661","display_name":"Mark A. Goldsmith","orcid":"https://orcid.org/0000-0001-8833-6841","observed_orcids":["https://orcid.org/0000-0001-8833-6841"]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark A. Goldsmith","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA;","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056487008","display_name":"Jan A.M. Smith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jan A. Smith","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA;","institution_ids":["https://openalex.org/I4210100604"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"79","issue":"13_Supplement","first_page":"5019","last_page":"5019"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.8730000257492065,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.8730000257492065,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.11420000344514847,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.007799999788403511,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/shp2","display_name":"SHP2","score":0.9279999732971191},{"id":"https://openalex.org/keywords/allosteric-inhibition","display_name":"allosteric inhibition","score":0.9010000228881836},{"id":"https://openalex.org/keywords/csf1r-signaling","display_name":"CSF1R signaling","score":0.9929999709129333},{"id":"https://openalex.org/keywords/tumor-associated-macrophages","display_name":"tumor-associated macrophages","score":0.9340000152587891},{"id":"https://openalex.org/keywords/m2-macrophages","display_name":"M2 macrophages","score":0.8790000081062317},{"id":"https://openalex.org/keywords/macrophage-polarization","display_name":"macrophage polarization","score":0.8640000224113464},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.8799999952316284},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.7799999713897705},{"id":"https://openalex.org/keywords/myeloid-derived-suppressor-cells","display_name":"myeloid-derived suppressor cells","score":0.859000027179718},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.7379999756813049},{"id":"https://openalex.org/keywords/ras-mapk-pathway","display_name":"RAS/MAPK pathway","score":0.8180000185966492},{"id":"https://openalex.org/keywords/checkpoint-blockade","display_name":"checkpoint blockade","score":0.4390000104904175},{"id":"https://openalex.org/keywords/ct26-cells","display_name":"CT26 cells","score":0.6269999742507935}],"concepts":[{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.6058821678161621},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5645685791969299},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.5119229555130005},{"id":"https://openalex.org/C166342909","wikidata":"https://www.wikidata.org/wiki/Q845326","display_name":"Allosteric regulation","level":3,"score":0.5062441229820251},{"id":"https://openalex.org/C2776682551","wikidata":"https://www.wikidata.org/wiki/Q21072584","display_name":"Macrophage polarization","level":4,"score":0.4731237292289734},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4613156318664551},{"id":"https://openalex.org/C193419808","wikidata":"https://www.wikidata.org/wiki/Q1645075","display_name":"Acquired immune system","level":3,"score":0.4578082263469696},{"id":"https://openalex.org/C2779341262","wikidata":"https://www.wikidata.org/wiki/Q182581","display_name":"Immunity","level":3,"score":0.4539506137371063},{"id":"https://openalex.org/C136449434","wikidata":"https://www.wikidata.org/wiki/Q428253","display_name":"Innate immune system","level":3,"score":0.4437859058380127},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.4313013553619385},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.4202738106250763},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4141484797000885},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.41199567914009094},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3991038203239441},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3847297430038452},{"id":"https://openalex.org/C2779244956","wikidata":"https://www.wikidata.org/wiki/Q184204","display_name":"Macrophage","level":3,"score":0.38090333342552185},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3184470534324646},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.30559635162353516},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.29656991362571716},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2857128381729126},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.13663563132286072}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2019-5019","doi":"https://doi.org/10.1158/1538-7445.am2019-5019","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2019-5019","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3021048814","https://openalex.org/W2912551658","https://openalex.org/W3180475939","https://openalex.org/W2803801423","https://openalex.org/W4282914015","https://openalex.org/W4294011762","https://openalex.org/W3089940214","https://openalex.org/W2982315700","https://openalex.org/W3119111229","https://openalex.org/W3123801310"],"abstract_inverted_index":{"Abstract":[0],"The":[1,135],"protein-tyrosine":[2],"phosphatase":[3],"SHP2":[4,17,36,172,208,249,266,329,355,397,438],"promotes":[5],"oncogenic":[6],"RAS/MAPK":[7],"pathway":[8],"activation":[9],"in":[10,42,72,80,85,114,122,126,180,203,213,224,235,300,334,338,371],"different":[11],"tumor":[12,40,45,65,82,302,340,388,448],"types.":[13],"In":[14,175,206,231,288,324],"immune":[15,83,260,314,336,381,389],"cells,":[16,128],"binds":[18],"to":[19,93,142,154,200,283,290,407,452],"phosphorylated":[20],"ITIM":[21],"and":[22,89,124,188,218,255,321,347,398,442],"ITAM":[23],"domains":[24],"on":[25,147,161,173,268,312],"regulatory":[26],"receptors,":[27],"including":[28,316],"PD-1.":[29],"We":[30],"have":[31],"shown":[32],"that":[33,248,284,307,328,392],"RMC-4550,":[34,291],"a":[35,155,165,168,297,331,358,400],"allosteric":[37],"inhibitor,":[38],"attenuates":[39],"growth":[41,66,370],"syngeneic":[43,183],"mouse":[44],"models":[46],"with":[47,59,78,106,119,132,362],"effects":[48,129,311],"equivalent":[49],"to,":[50],"or":[51,196],"greater":[52],"than":[53],"those":[54],"of":[55,98,116,137,157,167,171,178,241,257,265,279,285,318,351,367,378,386,437,446,458],"checkpoint":[56,94,133],"inhibitors.":[57],"Consistent":[58],"anti-tumor":[60,277,380,453],"immunity":[61,163,454],"as":[62,374,376],"the":[63,81,87,96,138,145,158,181,201,238,253,263,269,276,313,339,349,387,459],"mechanism,":[64],"inhibition":[67,209,250,267,356,366,436],"(TGI)":[68],"was":[69,76,102,141,281],"not":[70,130,227,295],"observed":[71],"immunocompromised":[73],"mice.":[74],"TGI":[75],"associated":[77,449],"changes":[79],"microenvironment,":[84],"both":[86,319,343],"adaptive":[88,162,320],"innate":[90,322],"arms.":[91],"Similar":[92],"blockade,":[95,198],"frequency":[97],"CD8+T":[99,193],"cell":[100,194,222,369],"infiltrates":[101],"increased":[103,189],"upon":[104,396],"treatment":[105,234],"RMC-4550.":[107],"Polarized":[108],"macrophage":[109,149],"populations":[110],"were":[111],"significantly":[112,185],"shifted":[113],"favor":[115],"antitumor":[117],"immunity,":[118],"marked":[120],"increases":[121],"M1":[123],"decreases":[125],"M2":[127,447],"seen":[131],"blockade.":[134,287],"objective":[136],"present":[139],"study":[140],"determine":[143],"if":[144],"effect":[146,170,264],"tumor-associated":[148],"(TAM)":[150],"polarization":[151],"is":[152],"secondary":[153],"release":[156],"biochemical":[159],"brakes":[160],"and/or":[164],"result":[166],"direct":[169,365,384],"TAMs.":[174],"vivo":[176],"administration":[177],"RMC-4550":[179,233,280,308],"CT26":[182,301],"model":[184],"decreased":[186],"M2,":[187,225],"M1,":[190,228],"TAM":[191],"after":[192],"depletion":[195],"IFN\u03b3":[197],"similar":[199,282],"response":[202,382],"control":[204],"animals.":[205],"vitro,":[207],"attenuated":[210],"CSF1R":[211,270,286,440],"signaling":[212,271,441],"murine":[214],"bone":[215],"marrow-derived":[216],"macrophages":[217,450],"selectively":[219,443],"induced":[220],"apoptotic":[221],"death":[223],"but":[226],"polarized":[229],"macrophages.":[230,353],"addition,":[232],"vitro":[236],"reduced":[237],"suppressive":[239,258],"potential":[240],"human":[242],"M-MDSCs.":[243],"Collectively":[244],"these":[245],"observations":[246],"suggest":[247],"directly":[251],"impacts":[252],"survival":[254],"function":[256],"monocytic":[259],"cells.":[261],"Given":[262],"pathway,":[272],"we":[273,326],"assessed":[274],"whether":[275],"activity":[278],"contrast":[289],"anti-CSF1R":[292],"antibody":[293],"did":[294],"induce":[296],"significant":[298],"delay":[299],"growth.":[303],"These":[304],"results":[305],"confirm":[306],"has":[309],"pleiotropic":[310],"system":[315],"modulation":[317],"mechanisms.":[323],"summary,":[325],"propose":[327],"plays":[330],"central":[332],"role":[333],"inducing":[335],"suppression":[337],"microenvironment":[341,402],"by":[342,383],"inhibiting":[344],"T":[345],"cells":[346],"supporting":[348],"viability":[350,445],"pro-tumorigenic":[352],"Thus,":[354],"represents":[357],"novel":[359],"investigational":[360],"strategy":[361],"dual":[363],"activity:":[364],"cancer":[368],"certain":[372],"tumors":[373],"well":[375],"promotion":[377],"an":[379],"transformation":[385],"microenvironment.":[390],"Tumors":[391],"are":[393],"intrinsically":[394],"dependent":[395],"exhibit":[399],"myeloid-rich":[401],"could":[403],"be":[404],"particularly":[405],"susceptible":[406],"this":[408],"dual-mechanism":[409],"therapeutic":[410],"strategy.":[411],"Citation":[412],"Format:":[413],"Elsa":[414],"Quintana,":[415],"Chris":[416],"J.":[417,420],"Schulze,":[418],"Tiffany":[419],"Choy,":[421],"Darienne":[422],"R.":[423],"Myers,":[424],"Kasia":[425],"Mordec,":[426],"Dylan":[427],"Daniel,":[428],"Mark":[429],"A.":[430,433],"Goldsmith,":[431],"Jan":[432],"Smith.":[434],"Allosteric":[435],"suppresses":[439],"reduces":[444],"contributing":[451],"[abstract].":[455],"In:":[456],"Proceedings":[457],"American":[460],"Association":[461],"for":[462],"Cancer":[463,477],"Research":[464],"Annual":[465],"Meeting":[466],"2019;":[467],"2019":[468],"Mar":[469],"29-Apr":[470],"3;":[471],"Atlanta,":[472],"GA.":[473],"Philadelphia":[474],"(PA):":[475],"AACR;":[476],"Res":[478],"2019;79(13":[479],"Suppl):Abstract":[480],"nr":[481],"5019.":[482]},"counts_by_year":[],"updated_date":"2026-09-23T05:00:35.095934","created_date":"2019-07-12T00:00:00"}